A Phase 2 Clinical Study of KHK4827

PHASE2CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Moderate to Severe Plaque Psoriasis

Interventions

DRUG

KHK4827

DRUG

Placebo

Trial Locations (1)

For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin, Chiyoda-ku

All Listed Sponsors

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT01748539 - A Phase 2 Clinical Study of KHK4827 | Biotech Hunter | Biotech Hunter